Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 220

1.

[Effectiveness of Health Promotion Program Using Action Planning Strategy for Young Adults].

Kim SH, Kim MJ, Kim SH, Kim SY, Park CY, Bang JY.

J Korean Acad Nurs. 2019 Aug;49(4):461-471. doi: 10.4040/jkan.2019.49.4.461. Korean.

PMID:
31477675
2.

Introduction of a Program to Improve the Information Sharing System of Food Allergy Patients.

Ha JS, Kim SH, Lim SH, Ko TH, Choi SW, Lee HY, Kim KH.

Stud Health Technol Inform. 2019 Aug 21;264:1674-1675. doi: 10.3233/SHTI190591.

PMID:
31438287
3.

Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responses.

Shin HJ, Hyun JW, Kim SH, Park MS, Sohn EH, Baek SH, Kim BJ, Choi K, Oh J, Cho JY, Kwon O, Kim W, Kim JE, Min JH, Kim BJ, Oh SY, Bae JS, Park KH, Oh JH, Sohn SY, Jang MJ, Sung JJ, Kim HJ, Kim SM.

Mult Scler Relat Disord. 2019 Aug 5;35:209-214. doi: 10.1016/j.msard.2019.08.004. [Epub ahead of print]

PMID:
31401425
4.

Stretchable ECM Patch Enhances Stem Cell Delivery for Post-MI Cardiovascular Repair.

Kim IG, Hwang MP, Park JS, Kim SH, Kim JH, Kang HJ, Subbiah R, Ko UH, Shin JH, Kim CH, Choi D, Park K.

Adv Healthc Mater. 2019 Sep;8(17):e1900593. doi: 10.1002/adhm.201900593. Epub 2019 Jul 15.

PMID:
31304685
5.

Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up.

Hyun JW, Shin HJ, Jang H, Park NY, Kim SH, Kim HJ.

J Clin Neurol. 2019 Jul;15(3):328-333. doi: 10.3988/jcn.2019.15.3.328.

6.

[Reversals in Decisions about Life-Sustaining Treatment and Associated Factors among Older Patients with Terminal Stage of Cardiopulmonary Disease].

Choi JJ, Kim SH, Kim SW.

J Korean Acad Nurs. 2019 Jun;49(3):329-339. doi: 10.4040/jkan.2019.49.3.329. Korean.

PMID:
31266929
7.

D-π-A-Structured Porphyrins with Extended Auxiliary π-Spacers for Highly Efficient Dye-Sensitized Solar Cells.

Ji JM, Kim SH, Zhou H, Kim CH, Kim HK.

ACS Appl Mater Interfaces. 2019 Jul 10;11(27):24067-24077. doi: 10.1021/acsami.9b05510. Epub 2019 Jun 28.

PMID:
31204470
8.

Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey.

Cha RH, Kim SH, Bae EH, Yu M, Choi BS, Choi HY, Kang SW, Shin J, Han SY, Yang CW, Kang DH.

Kidney Res Clin Pract. 2019 Sep 30;38(3):373-381. doi: 10.23876/j.krcp.19.007.

9.

Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension.

Kim YI, Kim YA, Lee JW, Kim HJ, Kim SH, Kim SG, Kim JI, Kim JJ, Choi IJ.

Gut Liver. 2019 Jul 24. doi: 10.5009/gnl18510. [Epub ahead of print]

10.

Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis.

Hyun JW, Kim Y, Kim G, Kim SH, Kim HJ.

Mult Scler. 2019 Mar 26:1352458519840757. doi: 10.1177/1352458519840757. [Epub ahead of print]

PMID:
30912689
11.

Cytotoxic Furan- and Pyrrole-Containing Scalarane Sesterterpenoids Isolated from the Sponge Scalarispongia sp.

Lee YJ, Kim SH, Choi H, Lee HS, Lee JS, Shin HJ, Lee J.

Molecules. 2019 Feb 27;24(5). pii: E840. doi: 10.3390/molecules24050840.

12.

Bioimpedance spectroscopy-guided fluid management in peritoneal dialysis patients with residual kidney function: A randomized controlled trial.

Yoon HE, Kwon YJ, Shin SJ, Lee SY, Lee S, Kim SH, Lee EY, Shin SK, Kim YS.

Nephrology (Carlton). 2019 Jan 31. doi: 10.1111/nep.13571. [Epub ahead of print]

PMID:
30706575
13.

Aerosol transmission of severe fever with thrombocytopenia syndrome virus during resuscitation.

Moon J, Lee H, Jeon JH, Kwon Y, Kim H, Wang EB, Seo CW, Sung SA, Kim SH, Seok H, Choi WS, Choi W, Park DW.

Infect Control Hosp Epidemiol. 2018 Dec 19:1-4. doi: 10.1017/ice.2018.330. [Epub ahead of print] Erratum in: Infect Control Hosp Epidemiol. 2019 May;40(5):620.

PMID:
30565531
14.

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.

Mealy MA, Mossburg SE, Kim SH, Messina S, Borisow N, Lopez-Gonzalez R, Ospina JP, Scheel M, Yeshokumar AK, Awad A, Leite MI, Arango JJ, Paul F, Palace J, Kim HJ, Levy M.

Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.

PMID:
30554040
15.

Seroprevalence of Pertussis in Healthcare Workers without Adult Pertussis Vaccine Use at a University Hospital in Korea.

Choi WS, Kim SH, Park DW.

J Korean Med Sci. 2018 Nov 19;33(50):e321. doi: 10.3346/jkms.2018.33.e321. eCollection 2018 Dec 10.

16.

Individualized B cell-targeting therapy for neuromyelitis optica spectrum disorder.

Kim SH, Hyun JW, Kim HJ.

Neurochem Int. 2018 Dec 1:104347. doi: 10.1016/j.neuint.2018.11.022. [Epub ahead of print] Review.

17.

A one-step method for covalent bond immobilization of biomolecules on silica operated in aqueous solution.

Sim YK, Jung H, Kim SH, Park JW, Park WJ, Jun CH.

Chem Sci. 2018 Aug 24;9(41):7981-7985. doi: 10.1039/c8sc02565g. eCollection 2018 Nov 7.

18.

Severe B cell-mediated disease activation despite two cycles of alemtuzumab in a patient with multiple sclerosis.

Hyun JW, Kim Y, Kim G, Kim SH, Kim HJ.

Mult Scler. 2018 Nov 7:1352458518810261. doi: 10.1177/1352458518810261. [Epub ahead of print]

PMID:
30403365
19.

[Family Surrogates' Decision Regret and Psychological Stress about End-of-Life Cancer Treatments: Path Analysis].

Kim SH.

J Korean Acad Nurs. 2018 Oct;48(5):578-587. doi: 10.4040/jkan.2018.48.5.578. Korean.

PMID:
30396195
20.

Real-World Effectiveness of Disease-Modifying Therapies in Korean Patients with Relapsing Multiple Sclerosis.

Kim SH, Park MS, Kim W, Huh SY, Shin HJ, Hyun JW, Kim HJ.

J Clin Neurol. 2019 Jan;15(1):20-26. doi: 10.3988/jcn.2019.15.1.20. Epub 2018 Oct 26.

Supplemental Content

Loading ...
Support Center